Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Future Revascularization Evaluation in Patients With Diabetes Mellitus: Optimal Management of Multivessel Disease (FREEDOM)

NCT00086450 is registered in ClinicalTrials.gov with Valentin Fuster as lead sponsor.

NCT NCT00086450
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00086450 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Future Revascularization Evaluation in Patients With Diabetes Mellitus: Optimal Management of Multivessel Disease (FREEDOM)
Lead sponsor
Valentin Fuster
Phase
Phase 3
Overall status
Unknown status
Start date
April 30, 2004
Completion date
December 31, 2018
Enrollment
1,900 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular diseases, coronary disease, diabetes mellitus, heart diseases